Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma

Author： Chodak G.   Sharifi R.   Kasimis B.   Block N.L.   Macramalla E.   Kennealey G.T.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.46, Iss.6, 1995-12, pp. : 849-855

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of patients with metastatic urothelial carcinoma and impaired renal function with single-agent docetaxel - its role in patients with renal insufficiency and as salvage therapy

By Dimopoulos M.A.   Deliveliotis C.   Moulopoulos L.A.   Papadimitriou C.   Mitropoulos D.   Anagnostopoulos A.   Athanassiades P.   Dimopoulos C.  

Urology, Vol. 52, Iss. 1, 1998-07 ,pp. : 56-60

Elsevier

Access to resources Recommend Favorite

Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235) 1

By Kucuk O.   Fisher E.   Moinpour C.M.   Coleman D.   Hussain M.H.A.   Sartor A.O.   Chatta G.S.   Lowe B.A.   Eisenberger M.A.   Crawford E.D.  

Urology, Vol. 58, Iss. 1, 2001-07 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite

Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression

By Wirth M.   Tyrrell C.   Wallace M.   Delaere K.P.   Sanchez-Chapado M.   Ramon J.   Hetherington J.   Pina F.   Heynes C.F.   Borchers T.M.   Morris T.   Stone A.  

Urology, Vol. 58, Iss. 2, 2001-08 ,pp. : 146-150

Elsevier

Access to resources Recommend Favorite

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

By Schellhammer P.   Sharifi R.   Block N.   Soloway M.   Venner P.   Patterson A.L.   Sarosdy M.   Vogelzang N.   Jones J.   Kolvenbag G.  

Urology, Vol. 45, Iss. 5, 1995-05 ,pp. : 745-752

Elsevier

Access to resources Recommend Favorite

Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up

By Oh W.K.   Manola J.   Bittmann L.   Brufsky A.   Kaplan I.D.   Smith M.R.   Kaufman D.S.   Kantoff P.W.  

Urology, Vol. 62, Iss. 1, 2003-07 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite